17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells

Yoko Fukata, Xiao Yu, Hitomi Imachi, Takamasa Nishiuchi, Jingya Lyu, Kayoko Seo, Akihiro Takeuchi, Hisakazu Iwama, Hisashi Masugata, Hiroshi Hoshikawa, Naohisa Hosomi, Yasumasa Iwasaki, Koji Murao

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

High-density lipoprotein (HDL) mediates reverse cholesterol transport. In this process, the human homolog of the B class, type I scavenger receptor (SR-BI), CD36, and LIMPII analogous-1 (hSR-BI/CLA-1) facilitates the cellular uptake of cholesterol from HDL. In endothelial cells, HDL activates endothelial nitric oxide synthase (eNOS) via hSR-BI/CLA-1, and 17β-estradiol (E2) modulates nitric oxide (NO) synthesis. In this study, we elucidated the effect of E2 on hSR-BI/CLA-1 expression in human umbilical vein endothelial cells (HUVECs). HSR-BI/CLA-1 expression was examined by real-time PCR, western blot analysis and reporter gene assay in HUVECs incubated with E2. eNOS activity was assessed by detection of phosphorylation (Ser 1179) of eNOS. We investigated the effect of the constitutively active form or dominant negative form of protein kinase C on hSR-BI/CLA-1 promoter activity. Our results showed that E2 increased the endogenous expression of hSR-BI/CLA-1. E2 also enhanced the activity of the hSR-BI/CLA-1 promoter and the expression of its mRNA. However, bisindolylmaleimide I, an inhibitor of protein kinase C, blocked the stimulatory effect of E2 on hSR-BI/CLA-1 promoter activity. Moreover, constitutively active PKC increased the activity of the hSR-BI/CLA-1 promoter, and a dominant-negative mutant of PKC prevented E2 from stimulating promoter activity. In cells treated with E2, HDL stimulated the phosphorylation of serine 1179 of eNOS in HUVECs. These results suggested that E2 upregulates the expression of the endothelial hSR-BI/CLA-1 via the PKC pathway, which may be a novel mechanism of the anti-atherosclerotic potential of E2 in vascular endothelial cells.

Original languageEnglish
Pages (from-to)644-650
Number of pages7
JournalEndocrine
Volume46
Issue number3
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Scavenger Receptors
Protein Kinase C
Estradiol
Endothelial Cells
Gene Expression
Nitric Oxide Synthase Type III
Human Umbilical Vein Endothelial Cells
HDL Lipoproteins
Phosphorylation
1-(7-(2-hydroxyethyl)dodecahydro-3a-methyl-1H-benz(e)inden-3-yl)ethanone
CD36 Antigens
Reporter Genes
Serine
HDL Cholesterol
Real-Time Polymerase Chain Reaction
Nitric Oxide
Up-Regulation
Cell Count
Western Blotting
Cholesterol

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells. / Fukata, Yoko; Yu, Xiao; Imachi, Hitomi; Nishiuchi, Takamasa; Lyu, Jingya; Seo, Kayoko; Takeuchi, Akihiro; Iwama, Hisakazu; Masugata, Hisashi; Hoshikawa, Hiroshi; Hosomi, Naohisa; Iwasaki, Yasumasa; Murao, Koji.

In: Endocrine, Vol. 46, No. 3, 01.01.2014, p. 644-650.

Research output: Contribution to journalArticle

Fukata, Y, Yu, X, Imachi, H, Nishiuchi, T, Lyu, J, Seo, K, Takeuchi, A, Iwama, H, Masugata, H, Hoshikawa, H, Hosomi, N, Iwasaki, Y & Murao, K 2014, '17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells', Endocrine, vol. 46, no. 3, pp. 644-650. https://doi.org/10.1007/s12020-013-0134-5
Fukata, Yoko ; Yu, Xiao ; Imachi, Hitomi ; Nishiuchi, Takamasa ; Lyu, Jingya ; Seo, Kayoko ; Takeuchi, Akihiro ; Iwama, Hisakazu ; Masugata, Hisashi ; Hoshikawa, Hiroshi ; Hosomi, Naohisa ; Iwasaki, Yasumasa ; Murao, Koji. / 17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells. In: Endocrine. 2014 ; Vol. 46, No. 3. pp. 644-650.
@article{87e4cb6e7ca341d6b3802d1e64277e64,
title = "17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells",
abstract = "High-density lipoprotein (HDL) mediates reverse cholesterol transport. In this process, the human homolog of the B class, type I scavenger receptor (SR-BI), CD36, and LIMPII analogous-1 (hSR-BI/CLA-1) facilitates the cellular uptake of cholesterol from HDL. In endothelial cells, HDL activates endothelial nitric oxide synthase (eNOS) via hSR-BI/CLA-1, and 17β-estradiol (E2) modulates nitric oxide (NO) synthesis. In this study, we elucidated the effect of E2 on hSR-BI/CLA-1 expression in human umbilical vein endothelial cells (HUVECs). HSR-BI/CLA-1 expression was examined by real-time PCR, western blot analysis and reporter gene assay in HUVECs incubated with E2. eNOS activity was assessed by detection of phosphorylation (Ser 1179) of eNOS. We investigated the effect of the constitutively active form or dominant negative form of protein kinase C on hSR-BI/CLA-1 promoter activity. Our results showed that E2 increased the endogenous expression of hSR-BI/CLA-1. E2 also enhanced the activity of the hSR-BI/CLA-1 promoter and the expression of its mRNA. However, bisindolylmaleimide I, an inhibitor of protein kinase C, blocked the stimulatory effect of E2 on hSR-BI/CLA-1 promoter activity. Moreover, constitutively active PKC increased the activity of the hSR-BI/CLA-1 promoter, and a dominant-negative mutant of PKC prevented E2 from stimulating promoter activity. In cells treated with E2, HDL stimulated the phosphorylation of serine 1179 of eNOS in HUVECs. These results suggested that E2 upregulates the expression of the endothelial hSR-BI/CLA-1 via the PKC pathway, which may be a novel mechanism of the anti-atherosclerotic potential of E2 in vascular endothelial cells.",
author = "Yoko Fukata and Xiao Yu and Hitomi Imachi and Takamasa Nishiuchi and Jingya Lyu and Kayoko Seo and Akihiro Takeuchi and Hisakazu Iwama and Hisashi Masugata and Hiroshi Hoshikawa and Naohisa Hosomi and Yasumasa Iwasaki and Koji Murao",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s12020-013-0134-5",
language = "English",
volume = "46",
pages = "644--650",
journal = "Endocrine",
issn = "0969-711X",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - 17β-Estradiol regulates scavenger receptor class BI gene expression via protein kinase C in vascular endothelial cells

AU - Fukata, Yoko

AU - Yu, Xiao

AU - Imachi, Hitomi

AU - Nishiuchi, Takamasa

AU - Lyu, Jingya

AU - Seo, Kayoko

AU - Takeuchi, Akihiro

AU - Iwama, Hisakazu

AU - Masugata, Hisashi

AU - Hoshikawa, Hiroshi

AU - Hosomi, Naohisa

AU - Iwasaki, Yasumasa

AU - Murao, Koji

PY - 2014/1/1

Y1 - 2014/1/1

N2 - High-density lipoprotein (HDL) mediates reverse cholesterol transport. In this process, the human homolog of the B class, type I scavenger receptor (SR-BI), CD36, and LIMPII analogous-1 (hSR-BI/CLA-1) facilitates the cellular uptake of cholesterol from HDL. In endothelial cells, HDL activates endothelial nitric oxide synthase (eNOS) via hSR-BI/CLA-1, and 17β-estradiol (E2) modulates nitric oxide (NO) synthesis. In this study, we elucidated the effect of E2 on hSR-BI/CLA-1 expression in human umbilical vein endothelial cells (HUVECs). HSR-BI/CLA-1 expression was examined by real-time PCR, western blot analysis and reporter gene assay in HUVECs incubated with E2. eNOS activity was assessed by detection of phosphorylation (Ser 1179) of eNOS. We investigated the effect of the constitutively active form or dominant negative form of protein kinase C on hSR-BI/CLA-1 promoter activity. Our results showed that E2 increased the endogenous expression of hSR-BI/CLA-1. E2 also enhanced the activity of the hSR-BI/CLA-1 promoter and the expression of its mRNA. However, bisindolylmaleimide I, an inhibitor of protein kinase C, blocked the stimulatory effect of E2 on hSR-BI/CLA-1 promoter activity. Moreover, constitutively active PKC increased the activity of the hSR-BI/CLA-1 promoter, and a dominant-negative mutant of PKC prevented E2 from stimulating promoter activity. In cells treated with E2, HDL stimulated the phosphorylation of serine 1179 of eNOS in HUVECs. These results suggested that E2 upregulates the expression of the endothelial hSR-BI/CLA-1 via the PKC pathway, which may be a novel mechanism of the anti-atherosclerotic potential of E2 in vascular endothelial cells.

AB - High-density lipoprotein (HDL) mediates reverse cholesterol transport. In this process, the human homolog of the B class, type I scavenger receptor (SR-BI), CD36, and LIMPII analogous-1 (hSR-BI/CLA-1) facilitates the cellular uptake of cholesterol from HDL. In endothelial cells, HDL activates endothelial nitric oxide synthase (eNOS) via hSR-BI/CLA-1, and 17β-estradiol (E2) modulates nitric oxide (NO) synthesis. In this study, we elucidated the effect of E2 on hSR-BI/CLA-1 expression in human umbilical vein endothelial cells (HUVECs). HSR-BI/CLA-1 expression was examined by real-time PCR, western blot analysis and reporter gene assay in HUVECs incubated with E2. eNOS activity was assessed by detection of phosphorylation (Ser 1179) of eNOS. We investigated the effect of the constitutively active form or dominant negative form of protein kinase C on hSR-BI/CLA-1 promoter activity. Our results showed that E2 increased the endogenous expression of hSR-BI/CLA-1. E2 also enhanced the activity of the hSR-BI/CLA-1 promoter and the expression of its mRNA. However, bisindolylmaleimide I, an inhibitor of protein kinase C, blocked the stimulatory effect of E2 on hSR-BI/CLA-1 promoter activity. Moreover, constitutively active PKC increased the activity of the hSR-BI/CLA-1 promoter, and a dominant-negative mutant of PKC prevented E2 from stimulating promoter activity. In cells treated with E2, HDL stimulated the phosphorylation of serine 1179 of eNOS in HUVECs. These results suggested that E2 upregulates the expression of the endothelial hSR-BI/CLA-1 via the PKC pathway, which may be a novel mechanism of the anti-atherosclerotic potential of E2 in vascular endothelial cells.

UR - http://www.scopus.com/inward/record.url?scp=84904539974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904539974&partnerID=8YFLogxK

U2 - 10.1007/s12020-013-0134-5

DO - 10.1007/s12020-013-0134-5

M3 - Article

VL - 46

SP - 644

EP - 650

JO - Endocrine

JF - Endocrine

SN - 0969-711X

IS - 3

ER -